BRMS1 and ovarian carcinoma: They further showed that transfection of BRMS1 complementary DNA (cDNA) into the highly malignant ovarian carcinoma cell line HO-8910PM significantly reduced cell adhesion, motility and invasion in vitro and also decreased the incidence of lung metastasis without affecting tumor growth.